A carregar...

Anti-IL-5 Biologicals Targeting Severe Late Onset Eosinophilic Asthma

Improved knowledge about the pathogenesis of asthma has facilitated the development of novel drugs and provided hope for patients with severe asthma. After the short- and long-term success of omalizumab in severe allergic phenotype, researchers have targeted patients with severe eosinophilic asthma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Turk Thorac J
Main Authors: Özyiğit, Leyla Pur, Öztürk, Ayşe Bilge, Bavbek, Sevim
Formato: Artigo
Idioma:Inglês
Publicado em: Turkish Thoracic Society 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7020889/
https://ncbi.nlm.nih.gov/pubmed/32163366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/TurkThoracJ.2019.180204
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!